On June 1, 2021 rescendo Biologics Ltd (Crescendo), a clinical stage immuno-oncology company developing novel, targeted T cell enhancing therapeutics, reported that senior members of the executive team will be participating at the following three conferences to meet investors to discuss the Company’s business strategy, technology, discovery platform and development programmes (Press release, Crescendo Bioscience, JUN 1, 2021, View Source [SID1234583332]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Kempen Life Sciences Crossover Conference (Virtual), 16 June 2021
JMP Securities Life Sciences Conference (Virtual), 17 June 2021
Presentation at 10:00 am EDT, 3:00 pm BST
BioTrinity (Virtual & London, UK), 21 June 2021
Presentation at 2:20 pm BST
If you are interested in meeting the team at these events, please contact the Company via email at [email protected].

Please refer to individual conference websites for further information and updated schedules.